Three new studies examine how a regulator of calcium homeostasis contributes to heart failure in humans and mice.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling
Nature Communications Open Access 23 July 2019
-
Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression
Nature Communications Open Access 28 April 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schmitt, J.P. et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410–1413 (2003).
Haghighi, K. et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 111, 869–876 (2003).
Song, Q. et al. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J. Clin. Invest. 111, 859–867 (2003).
Tada, M. & Toyofuku, T. Molecular regulation of phospholamban function and expression. Trends Cardiovasc. Med. 8, 330–340 (1998).
Hasenfuss, G. & Pieske, B. Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. 34, 951–969 (2002).
Marx, S.O. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365–376 (2000).
Minamisawa, S. et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313–322 (1999).
Sato, Y. et al. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J. Biol. Chem. 276, 9392–9399 (2001).
Freeman, K. et al. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J. Clin. Invest. 107, 967–974 (2001).
Hoshijima, M. et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8, 864–871 (2002).
del Monte, F., Harding, S.E., Dec, G.W., Gwathmey, J.K. & Hajjar, R.J. Targeting phospholamban by gene transfer in human heart failure. Circulation 105, 904–907 (2002).
Chien, K.R. Genomic circuits and the integrative biology of cardiac diseases. Nature 407, 227–232 (2000).
Towbin, J.A. & Bowles, N.E. The failing heart. Nature 415, 227–233 (2002).
Toyoshima, C. et al. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc. Natl. Acad. Sci. USA 100, 467–472 (2003).
Knoll, R. et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111, 943–955 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chien, K., Ross, J. & Hoshijima, M. Calcium and heart failure: the cycle game. Nat Med 9, 508–509 (2003). https://doi.org/10.1038/nm0503-508
Issue Date:
DOI: https://doi.org/10.1038/nm0503-508
This article is cited by
-
Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling
Nature Communications (2019)
-
Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression
Nature Communications (2016)
-
A Designed Zinc-finger Transcriptional Repressor of Phospholamban Improves Function of the Failing Heart
Molecular Therapy (2012)
-
Replacement of K‐Ras with H‐Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice
EMBO reports (2005)
-
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating
Nature Genetics (2004)